When the BBC presenter Lauren Laverne revealed she has smouldering myeloma, the diagnosis sounded more alarming than it is. Her situation is more subtle and nuanced than the word “myeloma” suggests.

Smouldering myeloma is better thought of as an early warning stage – a sign that some of the cells in her bone marrow are misbehaving – rather than a fully declared blood cancer. She is under specialist care, but she is well and does not need chemotherapy or targeted drugs at this point.

Celebrity disclosures like Laverne’s often trigger a wave of understandable worry: if a healthy‑seeming broadcaster can be told she has a blood disorder out of the blue, could the same be true for anyone? To answer that, it helps to step back and look at what smouldering myeloma actually is, where it comes from, and how doctors manage it.

Deep inside our bones lies the bone marrow, a soft, busy tissue that works like a round-the-clock factory. Its job is to make the blood cells we depend on: red cells to carry oxygen, white cells to fight infection, and platelets to help our blood clot. Among the white cells are plasma cells, which produce antibodies – Y-shaped proteins that recognise germs and help the immune system clear them.

Normally, plasma cells form a diverse and mixed population, each making slightly different antibodies tuned to different threats. In myeloma, a single rogue plasma cell breaks free from the usual controls and starts to multiply.

It produces and then fills the marrow with identical copies of itself. All of these clones make the same antibody, creating a single........

© The Conversation